Mucopolysaccharidosis I Disease: Tools for Discovery and Design of Chaperone Therapeutics Based on Unique Enzyme Production Systems and the Elucidation of the Structure of alpha-L-Iduronidase
James, Michael N
3 enregistrements totalisant 686,433.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $686,433 | 3 enregistrements |
Enregistrements
JAMES, Michael N
$387,633.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
James, Michael N
$248,800.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2020-2021
Canada
The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to: • Contribute to the global response to the 2019-nCoV outbreak; • Enhance local, national and/or internat...
James, Michael N
$50,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2020-2021
Canada
The objectives of Stream 1 are: •Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and •Generate timely evid...